Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
IASLC WCLC 2026
2026 ASCO GI
ASCO Breakthrough 2026
ASCO 2026
ESTRO 2026
Calendar
View All
Topics
AI in Oncology
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
IASLC WCLC 2026
«
1
»
Advertisement
Advertisement
Sep
02
Today In Oncology
ASCENT-04 Exploratory Analysis: Sacituzumab Govitecan Plus Pembrolizumab Improves PFS2, Delays Next Treatment
MD Anderson President Announces Retirement, Shares Leadership Transition Plans
High-Risk Prostate Cancer GETUG-AFU 18 Suggests a Role for Dose-Escalated Radiotherapy With Long-Term ADT
Radiation to the Thymus in NSCLC Treatment May Increase Risk of Metastasis
Osimertinib Plus Chemotherapy Significantly Extends Progression-Free Survival in EGFR/TP53-Mutated NSCLC
View More
Advertisement
